导管原位癌背景下乳腺磁共振成像的进展
Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.
作者信息
Amornsiripanitch Nita, Lam Diana L, Rahbar Habib
机构信息
University of Massachusetts Memorial Medical Center, Worcester, MA.
University of Washington, Seattle Cancer Care Alliance, Seattle, WA.
出版信息
Semin Roentgenol. 2018 Oct;53(4):261-269. doi: 10.1053/j.ro.2018.08.006. Epub 2018 Aug 30.
Abstract
Ductal carcinoma in situ (DCIS) of the breast is a pre-invasive breast malignancy with controversial clinical relevance and management. These lesions have increased in incidence with breast cancer screening programs and are associated with increasingly recognized clinical issues of overdiagnosis and overtreatment. This article discusses the imaging presentation of these lesions with emphasis on advances in breast MRI and its role in the management of DCIS.
摘要
乳腺导管原位癌（DCIS）是一种乳腺浸润前恶性肿瘤，其临床相关性和管理存在争议。随着乳腺癌筛查项目的开展，这些病变的发病率有所上升，并与越来越多被认识到的过度诊断和过度治疗等临床问题相关。本文讨论这些病变的影像学表现，重点是乳腺磁共振成像（MRI）的进展及其在DCIS管理中的作用。
相似文献
1
Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.
Semin Roentgenol. 2018 Oct;53(4):261-269. doi: 10.1053/j.ro.2018.08.006. Epub 2018 Aug 30.
2
Ductal carcinoma in situ and breast MRI.
Lancet. 2007 Aug 11;370(9586):459-60. doi: 10.1016/S0140-6736(07)61207-0.
3
Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
Eur J Radiol. 2016 Oct;85(10):1701-1707. doi: 10.1016/j.ejrad.2016.07.010. Epub 2016 Jul 19.
4
Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.
Breast Cancer Res Treat. 2016 Jul;158(1):139-148. doi: 10.1007/s10549-016-3858-0. Epub 2016 Jun 10.
5
Prediction Model For Extensive Ductal Carcinoma In Situ Around Early-Stage Invasive Breast Cancer.
Invest Radiol. 2016 Jul;51(7):462-8. doi: 10.1097/RLI.0000000000000255.
6
Pre-operative MRI in patients with ductal carcinoma in situ: the ongoing debate.
Eur Radiol. 2024 Jun;34(6):3967-3969. doi: 10.1007/s00330-023-10460-2. Epub 2023 Nov 24.
7
Comparison of mammography, ultrasound, and MRI in size assessment of ductal carcinoma in situ with histopathologic correlation.
Acta Radiol. 2017 Dec;58(12):1434-1441. doi: 10.1177/0284185117698860. Epub 2017 Mar 10.
8
Sensitivity of breast MRI for ductal carcinoma in situ appearing as microcalcifications only on mammography.
Clin Imaging. 2016 Nov-Dec;40(6):1207-1212. doi: 10.1016/j.clinimag.2016.08.001. Epub 2016 Aug 6.
9
Ductal Carcinoma in situ Detected during Prospective MR Imaging Screening of a Woman with a BRCA2 Mutation: The First Case Report in Japan.
Magn Reson Med Sci. 2017 Jul 10;16(3):265-269. doi: 10.2463/mrms.cr.2016-0090. Epub 2017 Jan 13.
10
The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Acta Radiol. 2014 Jul;55(6):668-75. doi: 10.1177/0284185113505086. Epub 2013 Sep 16.
引用本文的文献
1
Role of MRI in the Diagnosis of Ductal Carcinoma In Situ: A Retrospective Study.
J Clin Med. 2025 Apr 20;14(8):2842. doi: 10.3390/jcm14082842.
2
Prognostic Molecular Biomarkers in Breast Cancer Lesions with Non-Mass Enhancement on MR.
Diagnostics (Basel). 2024 Mar 30;14(7):747. doi: 10.3390/diagnostics14070747.
3
Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis.
Curr Oncol Rep. 2023 Apr;25(4):257-267. doi: 10.1007/s11912-023-01372-x. Epub 2023 Feb 7.
4
Comparison of the Magnetic Resonance Imaging Findings of Paget's Disease of the Breast and Malignant Tumor Invasion of the Nipple-Areola Complex.
Eur J Breast Health. 2021 Jun 24;17(3):265-273. doi: 10.4274/ejbh.galenos.2021.6091. eCollection 2021 Jul.
本文引用的文献
1
Breast ductal carcinoma in situ in an unscreened population: presentation, diagnosis and management at a single tertiary centre.
S Afr J Surg. 2017 Mar;55(1):4-9.
2
Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?
Ann Surg Oncol. 2017 Oct;24(10):2889-2897. doi: 10.1245/s10434-017-5931-2. Epub 2017 Aug 1.
3
MR Imaging for Diagnosis of Malignancy in Mammographic Microcalcifications: A Systematic Review and Meta-Analysis.
Radiology. 2017 Jun;283(3):692-701. doi: 10.1148/radiol.2016161106. Epub 2016 Oct 27.
4
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2016 Mar;14(3):324-54. doi: 10.6004/jnccn.2016.0037.
5
Cancer statistics: Breast cancer in situ.
CA Cancer J Clin. 2015 Nov-Dec;65(6):481-95. doi: 10.3322/caac.21321. Epub 2015 Oct 2.
6
Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?
Clin Imaging. 2016 Jan-Feb;40(1):125-9. doi: 10.1016/j.clinimag.2015.07.026. Epub 2015 Jul 26.
7
Rethinking the Standard for Ductal Carcinoma In Situ Treatment.
JAMA Oncol. 2015 Oct;1(7):881-3. doi: 10.1001/jamaoncol.2015.2607.
8
Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?
Radiology. 2015 Aug;276(2):371-80. doi: 10.1148/radiol.2015142304. Epub 2015 May 12.
9
Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
Med Sci Monit. 2015 Feb 1;21:376-82. doi: 10.12659/MSM.892534.
10
Accuracy of 3 T versus 1.5 T breast MRI for pre-operative assessment of extent of disease in newly diagnosed DCIS.
Eur J Radiol. 2015 Apr;84(4):611-6. doi: 10.1016/j.ejrad.2014.12.029. Epub 2015 Jan 8.
Zotero 插件